Analyses for phosphoproteins in activated T lymphocytes using Maldi-MS/MS method.
Analyses for phosphoproteins in activated T lymphocytes using Maldi-MS/MS method.
批准号:
15510165
负责人:
IRIE Atsushi
金额:
$2.3万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Although it has been believed that T lymphocytes(T cells) strictly recognize their cognate antigenic peptides, we found that one amino acid residue-substituted analogue peptide/HLA-DR4 complexes over-expressed on the surface of mouse L cells successfully stimulated the cognate human T cell clone and induced strong proliferative response. This phenomenon suggests that an amino acid sequence with close similarity to the non-self antigenic peptide in a self protein may stimulate unwanted T cell activation that may cause autoimmune diseases. To find out molecules involved in the T cell activation process, we used a panel of inhibitors that suppressed the T cell responses. The results suggested the involvement of protein kinase Cμ(PKCμ) and actually, activation of PKCμ was observed in the T cells stimulated with the analogue peptide/HLA-DR4.To seek for the role of PKCμ in the T cell activation pathway, we carried out the Maldi-MS/MS analyses using the Qstar Pulser i high performance mass-sp … More ectrometer and found that the kinase present in the T cells was not PKCμ but protein kinase D2(PKD2), a closely related kinase to PKCμ. Expression of GFP-tagged PKD2 in the human leukemic T cell line Jurkat revealed that PKD2 was mainly present in the cytosol and a fraction of the kinase translocated to the nucleus after TCR stimulation. To search for the possible substrates of PKD2 in the nucleus, we performed proteomic analyses using the nuclear extract of Jurkat cells and identified three tentative substrate proteins, all of which had the putative PKCμ phsophorylation site(Leu/Ile-X-X-X-X-Ser).Also, to find out other molecules involved in the T cell activation process, we performed proteomic analyses of phosphoproteins. Also, to find out other molecules involved in the T cell activation process, we performed proteomic analyses of phosphoproteins prepared from unstimulated, stimulated with wild-type peptide/HLA-DR4 and stimulated with analgue peptide/HLA-DR4 T cells and analyzed with Qstar. More that 40 phosphoproteins were identified and some of which were specifically phosphorylated in the T cells stimulated with the analgue peptide/HLA-DR4. Less
期刊论文(50)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Nishimura Y.他: "Degenerate recognition and response of human CD4^+ Th cell clones : Implications for basic and applied immunology"Mol.Immunol.. 40. 1089-1094 (2004)
Nishimura Y.等人:“人CD4^+Th细胞克隆的简并识别和反应:对基础和应用免疫学的启示”Mol.Immunol.. 40. 1089-1094 (2004)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Unique T-cell proliferation associated with PKCu activation and impaired Zap-70 phosphorylation in recognition of overexpressed HLA-DR/partially agonistic peptide complexes.
与 PKCu 激活和 Zap-70 磷酸化受损相关的独特 T 细胞增殖,可识别过度表达的 HLA-DR/部分激动肽复合物。
DOI:
--
发表时间:
2003
期刊:
Eur.J.Immunol. 33
影响因子:
--
作者:
[Irie A. 他]
通讯作者:
Irie A. 他
植村靖史, 入江厚, 西村泰治: "移植・輸血検査学:HLAからゲノム医学へ"講談社(in press). (2004)
Yasushi Uemura、Atsushi Irie、Taiji Nishimura:“移植/输血测试:从 HLA 到基因组医学”讲谈社(出版中)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
DOI:
10.1016/j.amjcard.2004.02.070
发表时间:
2004-06
期刊:
The American journal of cardiology
影响因子:
--
作者:
[Tomoko Tanaka;H. Soejima;N. Hirai;T. Sakamoto;M. Yoshimura;I. Kajiwara;Y. Miyao;K. Fujimoto;H. Miyagi;A. Irie;Y. Nishimura;H. Ogawa]
通讯作者:
Tomoko Tanaka;H. Soejima;N. Hirai;T. Sakamoto;M. Yoshimura;I. Kajiwara;Y. Miyao;K. Fujimoto;H. Miyagi;A. Irie;Y. Nishimura;H. Ogawa
広範囲 血液・尿化学検査、免疫学的検査(第六版)-その数値をどう読むか-「インテグリンファミリー」
广泛的血液/尿液化学测试、免疫学测试(第6版)-如何读取数值-《整合素家族》
DOI:
--
发表时间:
2005
期刊:
影响因子:
--
作者:
[Miyoshi, H., 入江 厚(分担)]
通讯作者:
入江 厚(分担)
共 18 条
Mechanism for cell fusion based on phospholipid dynamics in osteoclasts
-
批准号:17K19737
-
项目类别:Grant-in-Aid for Challenging Research (Exploratory)
-
资助金额:$3.99万
-
财政年份:2017
-
负责人:IRIE Atsushi
-
依托单位:
Phospholipid dynamics in osteoclast fusion
-
批准号:26670675
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.33万
-
财政年份:2014
-
负责人:IRIE Atsushi
-
依托单位:
Identification of substrate molecules on the host immune cells of bacterial proteases by using radioisotopes and mass spectrometry.
-
批准号:23510243
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.49万
-
财政年份:2011
-
负责人:IRIE Atsushi
-
依托单位:
Identification of kinase substrates by using radioactive ATP and LC-Maldi-MS/MS
-
批准号:20510191
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2008
-
负责人:IRIE Atsushi
-
依托单位:
Analyses for protein kinase D2 substrate using 2D-DIGE and Q-Trap mass-spectrometer.
-
批准号:17510167
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2005
-
负责人:IRIE Atsushi
-
依托单位:
国内基金
海外基金
登录
查看更多内容
疏肝补肾毓麟汤通过激活EP1/PKC/Nrf2通路抑制铁死亡改善少弱精子症的机制研究
-
批准号:JCZRLH202601317
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
铁蛋白磷酸化通过氧化应激-ROS/PKC轴调控亚细胞定位逆转卵巢癌耐药的机制研究
-
批准号:JCZRLH202601670
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
pH/ROS双响应Fe3O4-NP激活 PKCβ2/ACSL4抑制支架内再狭窄的作用及机制研究
-
批准号:2026JJ81986
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:段景锋
-
依托单位:
PKCδ/EGR1/PHGDH 轴调控丝氨酸代谢促进内皮细胞衰老在糖尿病创面血管新生障碍中的机制研究
-
批准号:JCZRQNB202600620
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
钩吻素子通过GlyR调控PKC/NLRP3介导的巨噬细胞焦亡以减轻急性肺损伤的机制研究
-
批准号:2026JJ60021
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:徐小庆
-
依托单位:
肿瘤相关成纤维细胞调控SPP1/ PKCα介导铁死亡在宫颈癌化疗耐药中的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:胡雪媚
-
依托单位:
PKC γ通过调节线粒体蛋白的磷酸化减轻脑缺血再灌注损伤的实验研究
-
批准号:2025JJ50618
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:曾六旺
-
依托单位:
基于F/IGF1R/PKC ζ 通路研究夏枯草中
Mesonolic acid B抑制RSV感染性肺炎的
作用机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:唐维
-
依托单位:
基于TAAR1-PKC-CRF信号通路探究肠道菌群代谢产物苯乙胺在腹泻型肠易激综合征发病中的作用机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:蔡力
-
依托单位:
基于5-HT–[Ca2+]i–PKC信号通路研究葎草制剂通过改善炎症诱导的内质网应激和间隙连接抑制促进糖尿病足创口愈合的机制
-
批准号:JCZRLH202501287
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位: